HELB and neoplasm: Furthermore, we analysed the published data from whole-genome sequencing of tumour DNA from 59 high-grade serous, 35 clear-cell and 29 endometrioid ovarian cancers [37] for point mutations in HELB. Only one pathogenic variant was identified in one of the endometrioid cases.